[{"address1": "28159 Avenue Stanford", "address2": "Suite 220", "city": "Valencia", "state": "CA", "zip": "91355", "country": "United States", "phone": "661 367 9170", "website": "https://www.avitamedical.com", "industry": "Medical Devices", "sector": "Healthcare", "longBusinessSummary": "AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.", "fullTimeEmployees": 207, "companyOfficers": [{"maxAge": 1, "name": "Mr. James M. Corbett", "age": 65, "title": "CEO, President & Executive Director", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 1156175, "exercisedValue": 0, "unexercisedValue": 466102}, {"maxAge": 1, "name": "Mr. David  O'Toole", "age": 64, "title": "Chief Financial Officer", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 574640, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Fencil", "title": "Senior Vice President of Global Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Katie  Bush Ph.D.", "title": "Senior Vice President of Scientific & Medical Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jessica  Ekeberg", "title": "Investor Relations Executive", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Nicole Linda Kelsey", "title": "Chief Legal & Compliance Officer and Corporate Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Debbie  Garner", "title": "Senior Vice President of Global Marketing & Strategy", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Rob  Hall", "title": "Senior Vice President of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Niraj  Doshi J.D., P.M.P., Ph.D.", "title": "Senior Vice President of Product Development & Program Management", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ron  Lagerquist", "title": "Senior Vice President of Quality Assurance & Regulatory Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 3, "compensationRisk": 8, "shareHolderRightsRisk": 5, "overallRisk": 6, "governanceEpochDate": 1727740800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 10.14, "open": 10.13, "dayLow": 9.92, "dayHigh": 10.59, "regularMarketPreviousClose": 10.14, "regularMarketOpen": 10.13, "regularMarketDayLow": 9.92, "regularMarketDayHigh": 10.59, "beta": 1.541, "forwardPE": -12.192771, "volume": 61891, "regularMarketVolume": 61891, "averageVolume": 136590, "averageVolume10days": 77910, "averageDailyVolume10Day": 77910, "bid": 10.1, "ask": 10.19, "bidSize": 100, "askSize": 100, "marketCap": 263015760, "fiftyTwoWeekLow": 7.51, "fiftyTwoWeekHigh": 18.93, "priceToSalesTrailing12Months": 4.858157, "fiftyDayAverage": 9.5936, "twoHundredDayAverage": 11.6547, "currency": "USD", "enterpriseValue": 254049760, "profitMargins": -0.92037004, "floatShares": 25045753, "sharesOutstanding": 25989700, "sharesShort": 1554611, "sharesShortPriorMonth": 1623164, "sharesShortPreviousMonthDate": 1723680000, "dateShortInterest": 1726185600, "sharesPercentSharesOut": 0.0598, "heldPercentInsiders": 0.00969, "heldPercentInstitutions": 0.23745, "shortRatio": 12.91, "shortPercentOfFloat": 0.060100004, "bookValue": 0.922, "priceToBook": 10.976139, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -49828000, "trailingEps": -1.94, "forwardEps": -0.83, "pegRatio": -0.05, "lastSplitFactor": "1:5", "lastSplitDate": 1593475200, "enterpriseToRevenue": 4.693, "enterpriseToEbitda": -4.744, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "RCEL", "underlyingSymbol": "RCEL", "shortName": "Avita Medical, Inc.", "longName": "AVITA Medical, Inc.", "firstTradeDateEpochUtc": 1337002200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "d9903933-9ef4-3f6b-9dc7-9265028fa3a5", "gmtOffSetMilliseconds": -14400000, "currentPrice": 10.12, "targetHighPrice": 21.0, "targetLowPrice": 9.0, "targetMeanPrice": 15.2, "targetMedianPrice": 15.0, "recommendationMean": 2.2, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 54056000, "totalCashPerShare": 2.08, "ebitda": -53549000, "totalDebt": 45090000, "quickRatio": 4.647, "currentRatio": 5.292, "totalRevenue": 54139000, "debtToEquity": 188.543, "revenuePerShare": 2.117, "returnOnAssets": -0.38979, "returnOnEquity": -1.07664, "freeCashflow": -36556752, "operatingCashflow": -53481000, "revenueGrowth": 0.293, "grossMargins": 0.86086, "ebitdaMargins": -0.98910004, "operatingMargins": -1.02685, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-10"}]